Journal
BRITISH JOURNAL OF HAEMATOLOGY
Volume 171, Issue 1, Pages 29-37Publisher
WILEY
DOI: 10.1111/bjh.13509
Keywords
myeloma; MRI myeloma; MRI; imaging; functional studies
Categories
Funding
- Cancer Research UK [16464] Funding Source: researchfish
- Cancer Research UK Funding Source: Medline
- Medical Research Council Funding Source: Medline
- Department of Health [C1060/A10334, C1060/A16464] Funding Source: Medline
Ask authors/readers for more resources
The recent consensus statement from the International Myeloma Working Group has introduced the role of whole body (WB) magnetic resonance imaging (MRI) into the management pathway for patients with multiple myeloma. The speed, coverage and high sensitivity of WB diffusion weighted (DW)-MRI and the unique capability to quantify both burden of disease and response to treatment has led to increasing implementation at leading centres worldwide for imaging malignant marrow disease, both primary and metastatic. WB DW-MRI is likely to have a significant impact on management decisions and pathways for patients with multiple myeloma. This review will introduce the basic principles of DW-MRI, present current evidence for patients with myeloma and will discuss practicalities and exciting future applications.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available